Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox

The recent emergence and global spread of the human Monkeypox virus (MPXV), including its transmission to non-endemic regions, have raised significant global health concerns. In this proof-of-concept study, we developed a recombinant protein-based MPXV vaccine candidate, employing an innovative and versatile multivalent, self-assembled nanocage protein scaffold. Two immunogenic antigens derived from the contemporary circulating MPXV strain have been incorporated into a self-assembled non-structural protein-10 (NSP-10) scaffold, expressed, and purified using an Escherichia coli expression system without a purification tag. The vaccine candidate elicited strong antibody responses in mice and conferred protection against the lethal Vaccinia virus in an intranasal and skin pock in vivo study. Additionally, an intranasal challenge with the MPXV strain clade IIb in immunized mice demonstrated promising outcomes, including a significant reduction in viral titres and eliciting a robust neutralizing antibody response. This study demonstrates a feasible, scalable, and cost-effective approach for the development of the MPXV vaccine.

Authors

Institutions

Publication Details

Journal
npj Vaccines
Published
2025-06-06
DOI
https://doi.org/10.1038/s41541-025-01174-1
Citations
2
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
2.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox

Vikas Maithil, Devendra Yadav, Sweety Samal, Rahul Ahuja et al.
2 citations
npj Vaccines
Poxvirus research and outbreaks
2.07
article

Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox

Vikas Maithil, Devendra Yadav, Sweety Samal, Rahul Ahuja, Sarjeet Singh, Shubbir Ahmed, Priyanka Priyadarsiny, Anup K. Singh, Preeti Vishwakarma, Ritika Khatri, Zaigham Abbas Rizvi, A. K. Awasthi, Vidya Mangala Prasad, Surbhi Mishra, Abhisek Chatterjee, Varun Kumar, Ananya Chatterjee, Pooja Yadav, Gurleen Kaur, Sangita Kumari Sinha, Akanksha Chauhan, Syed Khalid Ali, Kunal Tarane
article en
2 citations

Abstract

The recent emergence and global spread of the human Monkeypox virus (MPXV), including its transmission to non-endemic regions, have raised significant global health concerns. In this proof-of-concept study, we developed a recombinant protein-based MPXV vaccine candidate, employing an innovative and versatile multivalent, self-assembled nanocage protein scaffold. Two immunogenic antigens derived from the contemporary circulating MPXV strain have been incorporated into a self-assembled non-structural protein-10 (NSP-10) scaffold, expressed, and purified using an Escherichia coli expression system without a purification tag. The vaccine candidate elicited strong antibody responses in mice and conferred protection against the lethal Vaccinia virus in an intranasal and skin pock in vivo study. Additionally, an intranasal challenge with the MPXV strain clade IIb in immunized mice demonstrated promising outcomes, including a significant reduction in viral titres and eliciting a robust neutralizing antibody response. This study demonstrates a feasible, scalable, and cost-effective approach for the development of the MPXV vaccine.

npj VaccinesVol. 10(1)
Panacea Biotec (India) (IN), Translational Health Science and Technology Institute (IN), Indian Institute of Science Bangalore (IN)
Indian Institute of Science, Regional Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research, Translational Health Science and Technology Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Walter Reed Army Institute of Research
Zero hunger
Openalex Percentile: Top 14%
Poxvirus research and outbreaks
2.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.